Dense fine speckled nuclear immunofluorescence: A mildly reassuring antinuclear antibody pattern meriting consideration

نویسندگان

چکیده

Abstract Introduction Antinuclear antibodies (ANAs) are regarded as a hallmark of connective tissue diseases (CTDs) and play key role in their diagnosis, but the value some particular management patients disease prognosis is controversial. The mechanism underlying production ANAs CTDs, other chronic inflammatory conditions even healthy people, not completely elucidated. Anti‐DFS70 connected with dense fine speckled autoantigen 70 kD, known lens epithelium‐derived growth factor p75, subgroup ANAs. Their presence coexistence clinical significance matter debate. Methods Based on literature data, authors focused current knowledge explaining anti‐DFS70 selected CTDs. Results However, data ambiguous does fully support validity assay for specific CTD diagnosis. Most researchers claim that only one usually exclude diagnosis CTD. Nevertheless, its an excluding has predictive due to more favorable course Such situations may also suggest enhanced risk development future. Conclusions Although studies needed this field, it seems reasonable ascertain routine practice.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Frequency of dense fine speckled pattern in immunofluorescence screening test.

OBJECTIVE The presence of antinuclear antibodies (ANA), directed against intracellular antigens, is a distinctive feature of systemic autoimmune rheumatic diseases (SARDs). The standard test for antinuclear antibody screening is the indirect immunofluorescence (IIF). Anti-dense fine speckled 70 (anti-DFS70) antibodies were initially identified as an ANA IIF pattern from a patient with interstit...

متن کامل

Laboratorial significance of autoantibodies of dense fine speckled pattern

Purpose Indirect immunofluorescence (IIF) in Hep-2 cells is the standard screening test for antinuclear antibodies (ANA). Advances in this methodology have brought up a considerable increase in sensitivity and consequently a decrease in its specificity. This has resulted in an increasing number of positive tests in apparently healthy subjects. In particular, autoantibodies associated with the d...

متن کامل

Analysis of speckled fluorescent antinuclear antibody test antisera using electrofocused nuclear antigens.

Antibodies to different components of the extractable nuclear antigen (ENA) have been thought to be serological markers for clinical subsets of rheumatic diseases. However, incomplete characterization and standardization of antigenic components such as ribonucleoprotein (RNP), Sm, and SS-B (Ha), and the multiplicity of autoantibodies produced by different patients have confounded correlations b...

متن کامل

Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.

BACKGROUND For detection of anti-nuclear antibodies (ANAs) and antibodies to extractable nuclear antigens (ENAs), samples frequently are screened with indirect immunofluorescence (IIF); further determination of anti-ENA antibodies is performed only when the result is positive. However, because anti-ENA reactivities are found in samples with low fluorescence intensities, we determined anti-ENA a...

متن کامل

The Clinical Significance of the Dense Fine Speckled Immunofluorescence Pattern on HEp-2 Cells for the Diagnosis of Systemic Autoimmune Diseases

Antinuclear antibodies (ANAs) are a serological hallmark in the diagnosis of systemic autoimmune rheumatic diseases (SARD). The indirect immunofluorescence (IIF) assay on HEp-2 cells is a commonly used test for the detection of ANA and has been recently recommended as the screening test of choice by a task force of the American College of Rheumatology. However, up to 20% of apparently healthy i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Immunity, inflammation and disease

سال: 2023

ISSN: ['2050-4527']

DOI: https://doi.org/10.1002/iid3.1026